Novartis Prevails In Cancer Patient's Zometa Injury Suit

Law360, New York (September 19, 2012, 9:00 PM EDT) -- A Texas federal judge on Tuesday ruled against a cancer patient who sued Novartis Pharmaceuticals Corp. over a jaw injury she allegedly sustained after taking Zometa, handing Novartis the latest of several wins in multidistrict litigation over the bone drug in the past several months.

U.S. District Judge Ron Clark awarded Novartis summary judgment on Beulah Conklin’s claims, part of the ongoing multidistrict litigation over bone drugs Zometa and Aredia, saying the expert opinions she provided offered no support for her allegations she had developed osteonecrosis...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Conklin v. Novartis Pharmaceuticals Corporation


Case Number

9:11-cv-00178

Court

Texas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Ron Clark

Date Filed

October 28, 2011

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.